je.st
news
FDA expands lung cancer approval for Bristol-Myers' drug
2015-10-10 01:17:07| Biotech - Topix.net
The U.S. Food and Drug Administration on Friday expanded its approval of Bristol-Myers Squibb Co's immunotherapy drug Opdivo for patients with an additional form of advanced lung cancer. The agency said Opdivo may now be used in patients with non-squamous non-small cell lung cancer whose disease has progressed during or after platinum-based chemotherapy.
Tags: drug
approval
cancer
lung
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||
|
|||